Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research

Epigenetics refer to inheritable changes beyond DNA sequence that control cell identity and morphology. Epigenetics play key roles in development and cell fate commitments and highly impact the etiology of many human diseases. A well-known link between epigenetics and human disease is the X-linked M...

Full description

Saved in:
Bibliographic Details
Main Authors: Robby Mathew Zachariah, Mojgan Rastegar
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2012/415825
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552395172741120
author Robby Mathew Zachariah
Mojgan Rastegar
author_facet Robby Mathew Zachariah
Mojgan Rastegar
author_sort Robby Mathew Zachariah
collection DOAJ
description Epigenetics refer to inheritable changes beyond DNA sequence that control cell identity and morphology. Epigenetics play key roles in development and cell fate commitments and highly impact the etiology of many human diseases. A well-known link between epigenetics and human disease is the X-linked MECP2 gene, mutations in which lead to the neurological disorder, Rett Syndrome. Despite the fact that MeCP2 was discovered about 20 years ago, our current knowledge about its molecular function is not comprehensive. While MeCP2 was originally found to bind methylated DNA and interact with repressor complexes to inhibit and silence its genomic targets, recent studies have challenged this idea. Indeed, depending on its interacting protein partners and target genes, MeCP2 can act either as an activator or as a repressor. Furthermore, it is becoming evident that although Rett Syndrome is a progressive and postnatal neurological disorder, the consequences of MeCP2 deficiencies initiate much earlier and before birth. To comprehend the novel and challenging concepts in MeCP2 research and to design effective therapeutic strategies for Rett Syndrome, a targeted collaborative effort from scientists in multiple research areas to clinicians is required.
format Article
id doaj-art-d5c35734b7784356b8c987027974306b
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-d5c35734b7784356b8c987027974306b2025-02-03T05:58:52ZengWileyNeural Plasticity2090-59041687-54432012-01-01201210.1155/2012/415825415825Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 ResearchRobby Mathew Zachariah0Mojgan Rastegar1Regenerative Medicine Program, University of Manitoba, 745 Bannatyne Avenue, Winnipeg, MB, R3E 0J9, CanadaRegenerative Medicine Program, University of Manitoba, 745 Bannatyne Avenue, Winnipeg, MB, R3E 0J9, CanadaEpigenetics refer to inheritable changes beyond DNA sequence that control cell identity and morphology. Epigenetics play key roles in development and cell fate commitments and highly impact the etiology of many human diseases. A well-known link between epigenetics and human disease is the X-linked MECP2 gene, mutations in which lead to the neurological disorder, Rett Syndrome. Despite the fact that MeCP2 was discovered about 20 years ago, our current knowledge about its molecular function is not comprehensive. While MeCP2 was originally found to bind methylated DNA and interact with repressor complexes to inhibit and silence its genomic targets, recent studies have challenged this idea. Indeed, depending on its interacting protein partners and target genes, MeCP2 can act either as an activator or as a repressor. Furthermore, it is becoming evident that although Rett Syndrome is a progressive and postnatal neurological disorder, the consequences of MeCP2 deficiencies initiate much earlier and before birth. To comprehend the novel and challenging concepts in MeCP2 research and to design effective therapeutic strategies for Rett Syndrome, a targeted collaborative effort from scientists in multiple research areas to clinicians is required.http://dx.doi.org/10.1155/2012/415825
spellingShingle Robby Mathew Zachariah
Mojgan Rastegar
Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
Neural Plasticity
title Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
title_full Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
title_fullStr Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
title_full_unstemmed Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
title_short Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
title_sort linking epigenetics to human disease and rett syndrome the emerging novel and challenging concepts in mecp2 research
url http://dx.doi.org/10.1155/2012/415825
work_keys_str_mv AT robbymathewzachariah linkingepigeneticstohumandiseaseandrettsyndrometheemergingnovelandchallengingconceptsinmecp2research
AT mojganrastegar linkingepigeneticstohumandiseaseandrettsyndrometheemergingnovelandchallengingconceptsinmecp2research